Hydroxychloroquine

US Pharma Firm Gilead Sciences Likely To Seek Nod To Market Anti-Viral Drug Remdesivir In India

New Delhi: US pharmaceutical giant Gilead Sciences is likely to apply to India’s Central Drugs Standard Control Organisation (CDSCO) soon seeking marketing authorisation for its anti-viral drug remdesivir, which is…

View Post

Spotlight

HIV Drug May Replace Hydroxychloroquine In Covid Defence

Indian Council of Medical Research (ICMR) is planning to revise its treatment guidelines for Covid-19 and may drop hydroxychloroquine (HCQ) from the protocol due to increasing doubt over its effectiveness,…

View Post

COVID-19: 5 Hospitals Enrol In ICMR Study To Assess Efficacy Of Hydroxychloroquine

New Delhi: As a preventive medication against COVID-19 among healthcare personnel, five hospitals have enrolled so far for an observational study being conducted by ICMR to assess the efficacy…

View Post

COVID-19: 9 Hospitals Approved To Join WHO’s Solidarity Trial

Apex medical research body ICMR has said that 9 hospitals have so far been approved to conduct randomised controlled clinical trials under the WHO’s ‘Solidarity Trial’ to find an effective…

View Post

Spotlight